The UK Health Security Agency (UKHSA) has confirmed that two students from schools in Reading have been diagnosed with meningitis. One pupil attends Reading Blue Coat School, and the other is a student at Highdown Secondary School and Sixth Form. According to BBC, close contacts linked to these cases are being offered antibiotics as a precaution.
Key Takeaways
The UK Health Security Agency (UKHSA) confirmed that two pupils from Reading Blue Coat School and Highdown Secondary School have been diagnosed with meningitis. A student at Henley College in Oxfordshire has died from suspected meningitis, marking the third case linked to a social network among young people. Close contacts are being offered antibiotics as a precaution, and UKHSA emphasizes the risk to the wider public remains low.
- Two pupils in Reading confirmed with meningitis
- One student death at Henley College in Oxfordshire
- Social network links all three cases
- Antibiotics offered to close contacts
- Risk to wider public remains low
The UKHSA announced that a sixth-form pupil at Henley College in Oxfordshire died earlier this week from suspected meningitis, bringing the total number of confirmed cases connected through a social network to three. The agency has identified this network but has not provided fuller details on what links them. One case has been confirmed as Meningitis B (MenB), and further testing results are pending.
The UKHSA emphasized that the risk to the wider public remains low, although it described the situation in Reading as "evolving." Dr Shamez Ladhani, a consultant epidemiologist at the UKHSA, told BBC that while meningitis is rare, it can be very lethal. He noted that the strain identified from one of the three cases in Reading is distinct from those responsible for recent outbreaks in Kent and Dorset.
The agency has shared information about the infection with students and parents at all affected schools, urging young people to check their vaccination status. The MenACWY vaccine offered to pupils in Years 9 and 10 remains free on the NHS until age 25 but does not protect against all strains of meningitis. Olivier Picard, chair of the National Pharmacy Association, told BBC that pharmacies have seen a significant increase in demand for MenB vaccinations from worried parents.
How this summary was created
This summary synthesizes reporting from 4 independent publishers using AI. All sources are cited and linked below. NewsBalance is a news aggregator and media literacy tool, not a news publisher. AI-generated content may contain errors or inaccuracies — always verify important information with the original sources.